Hi Catherine,
Thank you for the kind words!
You know when I looked for MDS there should be 466 abstracts at the conference but many of them are sessions without papers, that we can read. In any case we can be sure that they are doing a lot of reseach about our disease
.
Since dx I have been looking for the very important issue - what treatment is the best for the individual patient - and this is the first interesting new about Vidaza. For ATG and Revlimid they have found the criteria for best response several years ago.
Kind regards
Birgitta-A